The molecule erythropoietin plays a role in the brain's response to injury. OU Distinguished Professor Mike Chopp and his team recently tested a recombinant (or genetically engineered) type of erythropoietin to treat head injuries.
Created by Brad Roth (roth@oakland.edu) on Thursday, March 12, 2009 Modified by Brad Roth (roth@oakland.edu) on Thursday, March 12, 2009 Article Start Date: Thursday, March 12, 2009